{"id":"low-dose-corticosteroids","safety":{"commonSideEffects":[{"rate":null,"effect":"Osteoporosis"},{"rate":null,"effect":"Infection (increased susceptibility)"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Corticosteroids work by translocating to the nucleus and modulating gene expression of inflammatory mediators, reducing T-cell activation, and decreasing production of cytokines like TNF-α and IL-6. At low doses, these effects provide anti-inflammatory benefits while minimizing systemic adverse effects associated with higher-dose therapy.","oneSentence":"Low-dose corticosteroids suppress immune and inflammatory responses by binding glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:22.017Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Systemic lupus erythematosus"},{"name":"Inflammatory bowel disease"},{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease"}]},"trialDetails":[{"nctId":"NCT07497282","phase":"PHASE2","title":"Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-03-26","conditions":"Rheumatoid Arthritis","enrollment":70},{"nctId":"NCT06780098","phase":"PHASE2","title":"Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-05-28","conditions":"Lung Neoplasm","enrollment":144},{"nctId":"NCT07287397","phase":"PHASE1, PHASE2","title":"Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS","status":"RECRUITING","sponsor":"Vector Y Therapeutics","startDate":"2025-12-19","conditions":"Amyotrophic Lateral Sclerosis","enrollment":12},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":"Chronic Low Back Pain","enrollment":108},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT06419413","phase":"","title":"A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-01-08","conditions":"Asthma","enrollment":355},{"nctId":"NCT06782529","phase":"PHASE4","title":"Knee Injections for Obese Patients With Knee Arthritis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-01-24","conditions":"Osteoarthritis of Knee","enrollment":40},{"nctId":"NCT06780202","phase":"PHASE2","title":"Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-27","conditions":"Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury","enrollment":180},{"nctId":"NCT07330245","phase":"","title":"Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-12-31","conditions":"Lupus Erythematosus, Systemic","enrollment":218},{"nctId":"NCT07447739","phase":"PHASE2","title":"Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively?","status":"NOT_YET_RECRUITING","sponsor":"Khang Nguyen","startDate":"2026-04","conditions":"Respiratory Distress Syndrome (RDS), Bronchopulmonary Dysplasia (BPD)","enrollment":100},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT03165734","phase":"PHASE3","title":"A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis","status":"RECRUITING","sponsor":"Swedish Orphan Biovitrum","startDate":"2017-06-26","conditions":"Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis","enrollment":399},{"nctId":"NCT04293562","phase":"PHASE3","title":"A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-07-21","conditions":"Acute Myeloid Leukemia","enrollment":1186},{"nctId":"NCT07216690","phase":"PHASE2","title":"Pregnenolone as a Treatment for Cannabis Intoxication","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":"Cannabis Intoxication","enrollment":20},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT07217405","phase":"PHASE4","title":"Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-12-19","conditions":"Osteoarthritis Hand, Osteoarthritis Wrist","enrollment":165},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT07222462","phase":"NA","title":"A Superiority Trial of Radiofrequency Ablation for Low Back Pain","status":"RECRUITING","sponsor":"University of Washington","startDate":"2026-02-04","conditions":"Chronic Low Back Pain (CLBP)","enrollment":300},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT07351916","phase":"","title":"Remission in Adults With Mild-to-moderate Asthma in Thailand","status":"NOT_YET_RECRUITING","sponsor":"Thammasat University","startDate":"2026-02-01","conditions":"Asthma, Mild-to-moderate Asthma, Asthma Control Level","enrollment":289},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT07152600","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Adenovirus Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-02-01","conditions":"Adenovirus Infections, Human","enrollment":262},{"nctId":"NCT07352865","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Chlamydia Psittaci Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Psittacosis","enrollment":100},{"nctId":"NCT07351500","phase":"PHASE3","title":"Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-01-15","conditions":"Influenza","enrollment":496},{"nctId":"NCT07337772","phase":"NA","title":"Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty","status":"RECRUITING","sponsor":"First Affiliated Hospital of Fujian Medical University","startDate":"2026-02-01","conditions":"Adrenal Cortex Hormones, Arthroplasty, Replacement, Knee, Anesthesia, Local","enrollment":120},{"nctId":"NCT07315555","phase":"NA","title":"Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Community Acquired Pneumonia","enrollment":90},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT02517489","phase":"PHASE3","title":"Community-Acquired Pneumonia : Evaluation of Corticosteroids","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2015-10-28","conditions":"Community Acquired Pneumonia","enrollment":952},{"nctId":"NCT02997605","phase":"PHASE4","title":"Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-31","conditions":"RheumatoId Arthritis","enrollment":102},{"nctId":"NCT06047171","phase":"PHASE2","title":"Rescue of Nephrons With ALE.F02 (RENAL-F02)","status":"RECRUITING","sponsor":"Alentis Therapeutics AG","startDate":"2023-09-07","conditions":"Glomerulonephritis Rapidly Progressive","enrollment":80},{"nctId":"NCT05276492","phase":"PHASE1","title":"Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2023-01-24","conditions":"Prostate Cancer, Prostate Adenocarcinoma, Prostate Neoplasm","enrollment":50},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT07192016","phase":"PHASE4","title":"129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2026-03","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":60},{"nctId":"NCT01284725","phase":"PHASE3","title":"Weaning of Immunosuppression in Nephritis of Lupus","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-02-16","conditions":"Nephritis of Lupus","enrollment":100},{"nctId":"NCT04202679","phase":"PHASE3","title":"Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-01-16","conditions":"Neurodermatitis","enrollment":160},{"nctId":"NCT04183335","phase":"PHASE3","title":"Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-12-12","conditions":"Neurodermatitis","enrollment":151},{"nctId":"NCT02114034","phase":"","title":"Cohort Analysis of Clinical and Biological Severe Childhood Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-11-12","conditions":"Severe Asthma","enrollment":362},{"nctId":"NCT07167251","phase":"","title":"Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-08-25","conditions":"Immune Related Adverse Events, Immune-Mediated Hepatitis, Cancer","enrollment":63},{"nctId":"NCT07152613","phase":"PHASE3","title":"Corticosteroids for PJP in Non-HIV Immunocompromised Adults","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2025-09-08","conditions":"Pneumocystis Jiroveci Pneumonia","enrollment":240},{"nctId":"NCT07152587","phase":"PHASE2, PHASE3","title":"Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2025-09-08","conditions":"Severe Community-acquired Pneumonia (sCAP)","enrollment":1500},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT06023641","phase":"PHASE2","title":"Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-03-13","conditions":"Rhabdomyosarcoma","enrollment":135},{"nctId":"NCT03112603","phase":"PHASE3","title":"A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2017-06-29","conditions":"Graft-versus-host Disease (GVHD)","enrollment":330},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT05197842","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis","status":"COMPLETED","sponsor":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","startDate":"2022-02-22","conditions":"ANCA-associated Vasculitis","enrollment":93},{"nctId":"NCT07098897","phase":"PHASE3","title":"To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2024-08-01","conditions":"IgA Nephropathy (IgAN)","enrollment":150},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT07057778","phase":"PHASE2","title":"Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-07-01","conditions":"Immune Thrombocytopenia (ITP)","enrollment":120},{"nctId":"NCT00001521","phase":"PHASE3","title":"Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"1995-06-08","conditions":"Congenital Adrenal Hyperplasia (CAH)","enrollment":66},{"nctId":"NCT06967363","phase":"","title":"Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-15","conditions":"Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain","enrollment":360},{"nctId":"NCT03952559","phase":"PHASE3","title":"A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2019-05-24","conditions":"Atopic Dermatitis","enrollment":516},{"nctId":"NCT06917768","phase":"NA","title":"Oral Corticosteroids' Role in Pediatric Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Hotel Dieu de France Hospital","startDate":"2022-12-09","conditions":"Pediatric Obstructive Sleep Apnea","enrollment":87},{"nctId":"NCT05365672","phase":"PHASE2","title":"Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation","status":"RECRUITING","sponsor":"TolerogenixX GmbH","startDate":"2022-05-04","conditions":"Kidney Transplantation","enrollment":126},{"nctId":"NCT04702022","phase":"NA","title":"Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients","status":"RECRUITING","sponsor":"University of Liege","startDate":"2021-01-04","conditions":"Kidney Transplant Rejection, Kidney Transplant; Complications","enrollment":50},{"nctId":"NCT05061771","phase":"PHASE3","title":"Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)","status":"WITHDRAWN","sponsor":"AKARI Therapeutics","startDate":"2022-05-06","conditions":"Bullous Pemphigoid","enrollment":""},{"nctId":"NCT05707156","phase":"","title":"Prospective Observational Study on the Incidence of Opportunistic Fungal Infections","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-07-05","conditions":"Pneumocystis Jirovecii Infection, Pneumocystis, Cryptococcosis","enrollment":12032},{"nctId":"NCT05560165","phase":"NA","title":"PET/CT Guided Robotic Arm-assisted Pain Palliation in Chronic Nociceptive Low Backache","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-01-01","conditions":"Chronic Low-back Pain, Nociceptive Pain","enrollment":85},{"nctId":"NCT02649790","phase":"PHASE1, PHASE2","title":"Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications","status":"COMPLETED","sponsor":"Karyopharm Therapeutics Inc","startDate":"2016-01","conditions":"Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":277},{"nctId":"NCT05401812","phase":"PHASE2","title":"Glucocorticoid Therapy for Acute Respiratory Distress Syndrome","status":"WITHDRAWN","sponsor":"National Taiwan University Hospital","startDate":"2022-07-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT02222155","phase":"PHASE2","title":"Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2015-02-04","conditions":"ANCA-associated Vasculitis","enrollment":42},{"nctId":"NCT01353313","phase":"PHASE3","title":"Hydrocortisone for BPD","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2011-08-11","conditions":"Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight","enrollment":800},{"nctId":"NCT06103227","phase":"PHASE2, PHASE3","title":"The Effect of Low Doses of Prednisone on the Prolongation of Pregnancy in Threatened Preterm Birth","status":"COMPLETED","sponsor":"University of Mostar","startDate":"2023-11-08","conditions":"Preterm Birth","enrollment":26},{"nctId":"NCT03312907","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-03-01","conditions":"Systemic Lupus Erythematosus","enrollment":292},{"nctId":"NCT01396278","phase":"PHASE2","title":"Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2011-07-01","conditions":"Asthma","enrollment":9},{"nctId":"NCT04159519","phase":"PHASE4","title":"A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-07-27","conditions":"Asthma, Severe Eosinophilic Asthma","enrollment":170},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT03564236","phase":"NA","title":"Nasal High-Flow in COPD","status":"RECRUITING","sponsor":"Marieke Duiverman","startDate":"2018-10-01","conditions":"COPD Exacerbation","enrollment":136},{"nctId":"NCT06697535","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)","status":"RECRUITING","sponsor":"Guangzhou JOYO Pharma Co., Ltd","startDate":"2023-05-24","conditions":"Neuromyelitis Optica Spectrum Disorders","enrollment":35},{"nctId":"NCT05714670","phase":"PHASE2","title":"The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-04-01","conditions":"Lupus Nephritis, SLE Nephritis","enrollment":72},{"nctId":"NCT00933231","phase":"PHASE3","title":"Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-08-17","conditions":"Kidney Transplantation","enrollment":281},{"nctId":"NCT01763580","phase":"PHASE4","title":"A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome","status":"COMPLETED","sponsor":"Astellas Pharma Korea, Inc.","startDate":"2012-07-16","conditions":"MCNS, Minimal Change Nephrotic Syndrome (MCNS)","enrollment":144},{"nctId":"NCT06275620","phase":"PHASE2","title":"A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)","status":"ENROLLING_BY_INVITATION","sponsor":"Beacon Therapeutics","startDate":"2023-11-14","conditions":"X-Linked Retinitis Pigmentosa","enrollment":24},{"nctId":"NCT06657066","phase":"PHASE2, PHASE3","title":"EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2021-12-06","conditions":"Asthma Patients","enrollment":74},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT06353958","phase":"","title":"MiSaver® Stem Cell Treatment for Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Honya Medical Inc","startDate":"2023-01-01","conditions":"Acute Myocardial Infarction","enrollment":30},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT05192499","phase":"NA","title":"Respiratory Dysbiosis in Preschool Children with Asthma: Predictive of a Severe Form","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2022-02-04","conditions":"Asthma in Children, Dysbiosis","enrollment":30},{"nctId":"NCT04824612","phase":"NA","title":"Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2021-08-30","conditions":"Keloid, Cicatrix","enrollment":4},{"nctId":"NCT00545324","phase":"PHASE4","title":"First Step With Singulair® Therapy (0476-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Asthma","enrollment":399},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03605654","phase":"PHASE2, PHASE3","title":"Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants","status":"WITHDRAWN","sponsor":"Medeor Therapeutics, Inc.","startDate":"2024-12","conditions":"Kidney Transplant Rejection","enrollment":""},{"nctId":"NCT02770807","phase":"PHASE3","title":"Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients","status":"COMPLETED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2017-03-02","conditions":"Nervous System Disease, Genetic Syndrome","enrollment":176},{"nctId":"NCT03764124","phase":"","title":"Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients.","status":"RECRUITING","sponsor":"University of Liege","startDate":"2007-01-01","conditions":"Kidney Transplantation","enrollment":1000},{"nctId":"NCT03299322","phase":"PHASE2","title":"A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2017-10-01","conditions":"Bronchial Asthma","enrollment":240},{"nctId":"NCT05679336","phase":"NA","title":"Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy","status":"RECRUITING","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2018-05-01","conditions":"Membranous Nephropathy - PLA2R Induced","enrollment":40},{"nctId":"NCT05510323","phase":"PHASE3","title":"Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2024-02-01","conditions":"Glomerulonephritis, IGA","enrollment":208},{"nctId":"NCT01742338","phase":"PHASE4","title":"Dose of Corticosteroids in COPD","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2012-05-03","conditions":"COPD","enrollment":89},{"nctId":"NCT05698966","phase":"NA","title":"Low Dose Antenatal Corticosteroids for Late Preterm Delivery","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2022-01-01","conditions":"Respiratory Morbidity, Preterm Labor","enrollment":1510},{"nctId":"NCT02062463","phase":"PHASE3","title":"Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-05-28","conditions":"Asthma","enrollment":485},{"nctId":"NCT05919316","phase":"NA","title":"The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa","status":"RECRUITING","sponsor":"National University of Malaysia","startDate":"2023-07-04","conditions":"Allergic Rhinitis","enrollment":40},{"nctId":"NCT00236925","phase":"EARLY_PHASE1","title":"Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia","status":"COMPLETED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2003-05","conditions":"Fibromyalgia","enrollment":30},{"nctId":"NCT03371667","phase":"PHASE3","title":"To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-08-16","conditions":"Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute","enrollment":102},{"nctId":"NCT06208098","phase":"NA","title":"Post-corticosteroid Insufficiency: Search for a Threshold Value for Cortisol at 8 Hours, Prospective Study","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-03-01","conditions":"Glucocorticoid-induced Adrenal Insufficiency","enrollment":170},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT03942887","phase":"PHASE3","title":"Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2019-05-03","conditions":"ANCA Associated Vasculitis","enrollment":100},{"nctId":"NCT05078021","phase":"","title":"Phenotyping Disease Severity in Asthma","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2022-04-21","conditions":"Asthma","enrollment":60},{"nctId":"NCT03773822","phase":"PHASE3","title":"Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.","status":"COMPLETED","sponsor":"CMC Ambroise Paré","startDate":"2019-04-19","conditions":"Cardiogenic Shock","enrollment":380}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"LUNG INFECTION"},{"count":2,"reaction":"MYCOBACTERIAL INFECTION"},{"count":1,"reaction":"GASTRIC PERFORATION"},{"count":1,"reaction":"OESOPHAGEAL PERFORATION"},{"count":1,"reaction":"PNEUMOMEDIASTINUM"},{"count":1,"reaction":"PNEUMOTHORAX"}],"_approvalHistory":[],"publicationCount":552,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["prednisone","methylprednisolone","Solumedrol"],"phase":"marketed","status":"active","brandName":"Low Dose Corticosteroids","genericName":"Low Dose Corticosteroids","companyName":"Rutgers, The State University of New Jersey","companyId":"rutgers-the-state-university-of-new-jersey","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Low-dose corticosteroids suppress immune and inflammatory responses by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Rheumatoid arthritis, Systemic lupus erythematosus, Inflammatory bowel disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}